Human albumin, a possible way of transmission of prion disease
Jørgensen, V.R.; Rosted, P.
Ugeskrift for Laeger 163(34) 4598; Discussion: 4598-4599
2001
ISSN/ISBN: 0041-5782 PMID: 11530573 Document Number: 540099
Document emailed within 1 workday
Related Documents
Dong, X.-P. 2007: Enforcement of prion research and prevalence of prion disease Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 21(3): 201Jørgensen, V.R.; Rosted, P. 2001: Non-disposable acupuncture needles are potential hazards of transmission of prion diseases Ugeskrift for Laeger 163(9): 1295-1296
Sakaguchi, S. 2007: Physiological functions of prion protein and its roles in the pathogenesis of prion diseases Seikagaku. Journal of Japanese Biochemical Society 79(9): 843-852
Liberski, P.P.; Bratosiewicz, J.; Waliś, A.; Kordek, R.; Jeffrey, M.; Brown, P. 2001: A special report I. Prion protein (PrP)--amyloid plaques in the transmissible spongiform encephalopathies, or prion diseases revisited Folia neuropathologica 39(4): 217-235
Azhyts'kyĭ, H.I.; Bélianova, L.I.; Malyĭ, K.D. 1975: Study of the amino acid composition of albumin fractions obtained from human serum albumin Ukrains'kyi Biokhimichnyi Zhurnal 47(1): 94-100
2000: Indications for the use of human albumin solutions: an expert report. Human albumin expert group Schweizerische Medizinische Wochenschrift 130(14): 516-522
Lundberg, P.O. 2001: Still a small problem with the mad cow disease? Creutzfeldt-Jakob disease and other prion diseases: current status Lakartidningen 98(1-2): 19-24
Van Bekkum, J.G. 1996: Prion disease in humans and animals Tijdschrift Voor Diergeneeskunde 121(6): 166
Murayama, S.; Saito, Y.; Hatsuta, H.; Sakiyama, Y. 2007: Neuropathological diagnosis of prion disease Nihon Rinsho. Japanese Journal of Clinical Medicine 65(8): 1401-1406
Adjou, K.T.; Seman, M. 2002: What are the prospects for pharmacological treatment of prion disease? Therapie 57(2): 123-127
Laplanche, J.L.; Launay, J.M.; Dreux, C. 1995: Molecular genetics of familial and sporadic forms of human prion diseases Annales Pharmaceutiques Francaises 53(5): 193-200
Lee, C.A.; Ironside, J.W.; Bell, J.E.; Giangrande, P.; Ludlam, C.; Esiri, M.M.; McLaughlin, J.E. 1998: Retrospective neuropathological review of prion disease in UK haemophilic patients Thrombosis and Haemostasis 80(6): 909-911
Goldhammer, Y.; Gabizon, R.; Meiner, Z.; Sadeh, M. 1993: An Israeli family with Gerstmann-Sträussler-Scheinker disease manifesting the codon 102 mutation in the prion protein gene Neurology 43(12): 2718-2719
Segat, L.; Crovella, S. 2012: HLA-G 14bp del/ins genetic variation: association with susceptibility to human immunodeficiency virus-1 vertical transmission but not with human immunodeficiency virus-1 infection through horizontal transmission Tissue Antigens 80(1): 12-13
Schalasta, G.; Roth, B. and Gisela Enders 2002: Rapid Ryping of the Codon 129 Polymorphism of the Human Prion Protein Gene by Combined Real-Time PCR and Melting Curve Analysis Clinical Laboratory 48(1-2): 25-30
Yamanoto, M.; Nakanishi, K.; Wada, T.; Nakai, T.; Kondo, M. 1974: Albumin Kyoto, albumin Otsu and albumin Shizuoka-2 Jinrui Idengaku Zasshi. Japanese Journal of Human Genetics 19(1): 49
Belpaire, F.M.; Vanderheeren, F.A.; Bogaert, M.G. 1975: Binding of thioridazine and some of its metabolites to human serum protein and human albumin Arzneimittel-Forschung 25(12): 1969-1971
Arnould, R.; Penasse, W.; Ewalenko, T.P.; Deloof, T.; Libert, A.; Vercammen-Grandjean, A.; Lejeune, F.J. 1984: A new test for phagocytosis of human alveolar macrophages in suspension, using 99mTc labelled human serum albumin particles Anticancer Research 4(4-5): 283-288
Terao, Y.; Hitoshi, S.; Shimizu, J.; Sakuta, M.; Kitamoto, T. 1992: Gerstmann-Sträussler-Scheinker disease with heterozygous codon change at prion protein codon 129 Rinsho Shinkeigaku 32(8): 880-883
Kornblatt, J.A.; Marchal, S.; Rezaei, H.; Balny, C. 2004: Characterization of a complex formed between human plasminogen and recombinant sheep prion: pressure and thermal sensitivity of complex formation Cellular and Molecular Biology 50(4): 387-396